Additionally, we can introduce pathogenic PIEZO1 Gain- or Loss-of-Function mutations15,18,19,69 in the PIEZO1-HaloTag hiPSCs for human disease modeling of PIEZO1 channelopathies. The gene discussed is PIEZO1; the disease is channelopathy.